Cargando…

A Novel Inactivated Intranasal Respiratory Syncytial Virus Vaccine Promotes Viral Clearance without Th2 Associated Vaccine-Enhanced Disease

BACKGROUND: Respiratory syncytial virus (RSV) is a leading cause of bronchiolitis and pneumonia in young children worldwide, and no vaccine is currently available. Inactivated RSV vaccines tested in the 1960's led to vaccine-enhanced disease upon viral challenge, which has undermined RSV vaccin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lindell, Dennis M., Morris, Susan B., White, Maria P., Kallal, Lara E., Lundy, Phillip K., Hamouda, Tarek, Baker, James R., Lukacs, Nicholas W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137595/ https://www.ncbi.nlm.nih.gov/pubmed/21789184 http://dx.doi.org/10.1371/journal.pone.0021823

Ejemplares similares

Intranasal immunization with W(80)5EC adjuvanted recombinant RSV rF-ptn enhances clearance of respiratory syncytial virus in a mouse model
por: Passmore, Crystal, et al.
Publicado: (2014)

Inactivated Viral Vaccines
por: Sanders, Barbara, et al.
Publicado: (2014)

Intranasal SARS-CoV-2 RBD decorated nanoparticle vaccine enhances viral clearance in the Syrian hamster model
por: Patel, DR, et al.
Publicado: (2022)

Bovine Respiratory Disease Vaccination Against Viral Pathogens: Modified-Live Versus Inactivated Antigen Vaccines, Intranasal Versus Parenteral, What Is the Evidence?
por: Chamorro, Manuel F., et al.
Publicado: (2020)

Unveiling Integrated Functional Pathways Leading to Enhanced Respiratory Disease Associated With Inactivated Respiratory Syncytial Viral Vaccine
por: Russell, Marsha S., et al.
Publicado: (2019)

Human immune responses elicited by an intranasal inactivated H5 influenza vaccine
por: Ainai, Akira, et al.
Publicado: (2020)

Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice
por: Hua, Tao, et al.
Publicado: (2022)

Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus
por: Smit, Joost J., et al.
Publicado: (2006)

Shape-dependent adjuvanticity of nanoparticle-conjugated RNA adjuvants for intranasal inactivated influenza vaccines
por: Tazaki, Taiyu, et al.
Publicado: (2018)

Formulation, High Throughput In Vitro Screening and In Vivo Functional Characterization of Nanoemulsion-Based Intranasal Vaccine Adjuvants
por: Wong, Pamela T., et al.
Publicado: (2015)

Immunity following intranasal administration of an inactivated, freeze-dried A/England/42/72 vaccine
por: Potter, C. W., et al.
Publicado: (1975)

In-line monitoring of surfactant clearance in viral vaccine downstream processing
por: Payne, Jessie, et al.
Publicado: (2021)

Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults
por: Ainai, Akira, et al.
Publicado: (2013)

Strategies for intranasal delivery of vaccines
por: Zaman, Mehfuz, et al.
Publicado: (2012)

Green Tea Catechin-Inactivated Viral Vaccine Platform
por: Lee, Yun H., et al.
Publicado: (2017)

Mucosal Immunity and Protective Efficacy of Intranasal Inactivated Influenza Vaccine Is Improved by Chitosan Nanoparticle Delivery in Pigs
por: Dhakal, Santosh, et al.
Publicado: (2018)

A single vaccination with an inactivated bovine respiratory syncytial virus vaccine primes the cellular immune response in calves with maternal antibody
por: van der Sluijs, Mirjam TW, et al.
Publicado: (2010)

Cost-effectiveness analysis of intranasal live attenuated vaccine (LAIV) versus injectable inactivated influenza vaccine (TIV) for Canadian children and adolescents
por: Tarride, Jean-Eric, et al.
Publicado: (2012)

Investigating Prime-Pull Vaccination through a Combination of Parenteral Vaccination and Intranasal Boosting
por: Roces, Carla B., et al.
Publicado: (2019)

Intranasal Therapeutic Peptide Vaccine Promotes Efficient Induction and Trafficking of Cytotoxic T Cell Response for the Clearance of HPV Vaginal Tumors
por: Sierra, Gloria, et al.
Publicado: (2020)

Notch ligand Delta-like 4 regulates disease pathogenesis during respiratory viral infections by modulating Th2 cytokines
por: Schaller, Matthew A., et al.
Publicado: (2007)

Cytokines: The Future of Intranasal Vaccine Adjuvants
por: Thompson, Afton L., et al.
Publicado: (2011)

Monoclonal Antibody against G Glycoprotein Increases Respiratory Syncytial Virus Clearance In Vivo and Prevents Vaccine-Enhanced Diseases
por: Lee, Hyo-Jeong, et al.
Publicado: (2017)

Intranasal COVID-19 vaccine: a modern vaccination approach
por: Shahnoor, Syeda, et al.
Publicado: (2023)

Caspase-1 Independent Viral Clearance and Adaptive Immunity Against Mucosal Respiratory Syncytial Virus Infection
por: Shim, Ye Ri, et al.
Publicado: (2015)

Replication and Clearance of Respiratory Syncytial Virus : Apoptosis Is an Important Pathway of Virus Clearance after Experimental Infection with Bovine Respiratory Syncytial Virus
por: Viuff, Birgitte, et al.
Publicado: (2002)

Changing partners at the dance: Variations in STAT concentrations for shaping cytokine function and immune responses to viral infections
por: Kallal, Lara E., et al.
Publicado: (2013)

Response to Bovine Viral Diarrhea Virus in Heifers Vaccinated with a Combination of Multivalent Modified Live and Inactivated Viral Vaccines
por: Falkenberg, Shollie M., et al.
Publicado: (2023)

Protection against Bovine Respiratory Syncytial Virus Afforded by Maternal Antibodies from Cows Immunized with an Inactivated Vaccine
por: Meyer, Gilles, et al.
Publicado: (2023)

A new inactivated Tritrichomonas foetus vaccine that improves genital clearance of the infection and calving intervals in cattle
por: Ortega-Mora, Luis Miguel, et al.
Publicado: (2022)

Efficacy of a live intranasal vaccine against parainfluenza type 3 and bovine respiratory syncytial virus in young calves with maternally derived antibodies
por: Metcalfe, Lucy, et al.
Publicado: (2020)

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults
por: Scaggs Huang, Felicia, et al.
Publicado: (2020)

Preparation and efficacy of freeze-dried inactivated vaccine against bovine viral diarrhea virus genotypes 1 and 2, bovine herpes virus type 1.1, bovine parainfluenza-3 virus, and bovine respiratory syncytial virus
por: Abd El Fadeel, Maha Raafat, et al.
Publicado: (2020)

Advantages of Intranasal Vaccination and Considerations on Device Selection
por: Birkhoff, M., et al.
Publicado: (2009)

Data describing IFNγ-mediated viral clearance in an adult mouse model of respiratory syncytial virus (RSV)
por: Eichinger, Katherine M., et al.
Publicado: (2017)

Benefits of Inactivated Vaccine and Viral Vector Vaccine Immunization on COVID-19 Infection in Kidney Transplant Recipients
por: Sutharattanapong, Napun, et al.
Publicado: (2022)

Intranasal Immunization Using Mannatide as a Novel Adjuvant for an Inactivated Influenza Vaccine and Its Adjuvant Effect Compared with MF59
por: Ren, Shu-Ting, et al.
Publicado: (2017)

Phase 1/2 Randomized Study of the Immunogenicity, Safety, and Tolerability of a Respiratory Syncytial Virus Prefusion F Vaccine in Adults With Concomitant Inactivated Influenza Vaccine
por: Falsey, Ann R, et al.
Publicado: (2021)

Vaccination of pregnant women with respiratory syncytial virus vaccine and protection of their infants
por: Madhi, Shabir A, et al.
Publicado: (2020)

Respiratory Syncytial Virus Vaccines: A Review of the Candidates and the Approved Vaccines
por: Topalidou, Xanthippi, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_qko5n17befhgvm24pn16lckp9c